Nilo Therapeutics · 2 weeks ago
Senior Accounting Manager / Controller
Nilo Therapeutics is an early-stage biotech company developing groundbreaking therapies for autoimmune and inflammatory diseases. They are seeking a Senior Accounting Manager / Controller to oversee all aspects of accounting operations, ensure the integrity of financial data, and support strategic decision-making through accurate and timely reporting.
BiotechnologyHealth CareTherapeuticsWellness
Responsibilities
Manage day-to-day accounting functions, including accounts receivable, accounts payable, fixed assets, and payroll
Process payroll administration
Manage the monthly, quarterly, and annual close processes, including journal entries and account reconciliations. Ensure timely and accurate close cycles, including consolidation, accruals, and intercompany eliminations (if applicable)
Own cap table management from a financial perspective, ensuring that institutional funding rounds and ESOP awards are accurately reflected in the company’s cap table management platform
Prepare timely and accurate financial statements and supporting documentation
Assist senior management in analyzing financial performance and identifying variances from budgets and forecasts
Develop financial reports for board meetings and investor communications
Assist in, and eventually lead the annual budgeting process, including the preparation of templates and coordinating with various departments
Own and maintain the budget-to-actuals process; drive monthly and quarterly variance analysis with functional leaders
Develop and document accounting policies and procedures to support scaling operations and ensure audit readiness. Ensure compliance with US GAAP, local, state, and federal regulations. Coordinate tax filings and ensure compliance with federal, state, and local tax regulations. Manage 1099 filings and sales/use tax as applicable
Coordinate with external auditors and tax consultants for audits and regulatory filings
Oversee treasury functions, including cash flow forecasting, liquidity planning, and banking relationships. Manage short- and long-term cash needs; optimize working capital strategies
Oversee the implementation and maintenance of accounting software and other financial systems
Identify opportunities to streamline processes and enhance financial management practices
Provide training and support to team members on new systems and procedures
Work closely with the CFO, legal team, and other senior leaders to provide financial insights and decision-support to senior leadership
Support long-range financial planning, modeling, and scenario analysis to support strategic financial initiatives
Manage relationships with external partners, including banks, auditors, and insurance brokers
Assist in administering equity plans and maintaining capitalization records
Qualification
Required
Bachelor's degree in Accounting, Finance, or a related field (CPA or equivalent certification preferred)
5+ years of progressive experience in accounting or financial management
Experience managing or closely supporting the full suite of Senior Accountant (or Controller) responsibilities in a scaling company (i.e., budgeting, forecasting, and budget vs. actuals analysis, as well as treasury management)
Strong understanding of US GAAP and relevant regulatory requirements
Proficiency with accounting and bookkeeping software (e.g., QuickBooks, Bill.com, Carta, etc.) and advanced MS Excel skills
Experience in designing and implementing internal controls and managing audits
Excellent organizational, analytical, and problem-solving skills
Strong communication skills with the ability to collaborate effectively across departments
Ability to thrive in a fast-paced, team-oriented, and dynamic environment
Preferred
Experience in a pre-IPO or startup environment, preferably in industries such as pharmaceutical, biotech, or life sciences, is a significant plus
Benefits
401K with employer contribution
Health/dental/vision
Commuter benefits
Company
Nilo Therapeutics
NILO Therapeutics is a biotechnology and therapeutics company.
Funding
Current Stage
Early StageTotal Funding
$110.6M2025-10-08Series A· $101M
2024-08-02Series Unknown· $9.6M
2024-08-02Debt Financing
Recent News
2025-11-19
vcnewsdaily.com
2025-10-18
Company data provided by crunchbase